Overview

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The study is conducted in Europe. The aim of this observational study is to assess glycaemic control while using liraglutide under normal clinical practice conditions in Belgium.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide